DrugPatentWatch Database Preview

Sweden Supplementary Protection Certificates

« Back to Dashboard

Supplementary Protection Certificates

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.

Country	Patent Number	Supplementary Protection Certificate	SPC Country	SPC Description	SPC Expiration
European Patent Office	1307486	1290022-1	Sweden	PRODUCT NAME: PASIREOTID; REG. NO/DATE: EU/1/12/753/001 20120424
European Patent Office	2209800	1490067-4	Sweden	PRODUCT NAME: COMBINATION OF INSULIN DEGLUDEC AND LIRAGLUTIDE; REG. NO/DATE: EU/1/14/974 20140918
European Patent Office	2203462	1490066-6	Sweden	PRODUCT NAME: SOFOSBUVIR; REG. NO/DATE: EU/1/13/894 20140117
European Patent Office	1436271	1490023-7	Sweden	PRODUCT NAME: VORTIOXETINE ELLER ETT FARMACEUTISKT GODTAGBART SYRAADDITIONSSALT DAERAV; REG. NO/DATE: EU/1/13/891 20131218
European Patent Office	1827461	1890010-0	Sweden	PRODUCT NAME: CLADRIBINE; REG. NO/DATE: EU/1/17/1212 20170824
European Patent Office	1534313	1590074-9	Sweden	PRODUCT NAME: EN KOMBINATION INNEFATTANDE FENYLEFRIN ELLER ETT FARMACEUTISKT ACCEPTABELT SALT DAERAV OCH KETOROLAK ELLER ETT FARMACEUTISKT ACCEPTABELT SALT DAERAV.; REG. NO/DATE: EU/1/15/1018 20150730
European Patent Office	2049522	1590007-9	Sweden	PRODUCT NAME: DACLATASVIR AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, ESPECIALLY DACLATASVIR DIHYDROCHLORIDE; REG. NO/DATE: EU/1/14/939 20140826